Prevalence of Aspirin or Clopidogrel Pharmacological Resistance in Ischemic Stroke: A Step Toward Precision Medicine

氯吡格雷 阿司匹林 医学 冲程(发动机) 内科学 P2Y12 人口 心脏病学 麻醉 工程类 环境卫生 机械工程
作者
Samantha Cencer,Laurel Packard,Alan T. Davis,Asad Ahrar,Małgorzata Miller,Nadeem Khan,Nabil Wees,Jiangyong Min
出处
期刊:CNS Neuroscience & Therapeutics [Wiley]
卷期号:31 (3): e70343-e70343 被引量:3
标识
DOI:10.1111/cns.70343
摘要

ABSTRACT Background and Objectives Currently, there is not sufficient data regarding the prevalence of resistance or inadequate platelet function inhibition with the use of antiplatelet therapy in patients with noncardioembolic stroke. This study was designed to evaluate the prevalence of antiplatelet inactivity to aspirin and clopidogrel in the setting of chronic use and presentation with primary or recurrent stroke. Methods Patients who were taking aspirin, clopidogrel, or both at the time of presentation for stroke were selected in this study. Those with confirmed stroke on MRI or clinically determined TIA and age > 18 years were included. A standard laboratory test, VerifyNow aspirin or P2Y12 assay, was utilized to assess the responsiveness to the platelet inhibitors. A total of 158 patients were identified, 52 presenting with primary stroke and 106 with recurrent stroke. Data were analyzed using chi‐squared or Fisher's exact as well as t ‐test analysis. Results Of the primary stroke population, 4% of patients demonstrated resistance to aspirin and 30% to clopidogrel. Of the patients presenting with recurrent stroke, 13% demonstrated resistance to aspirin and 38% to clopidogrel. The data also suggest increased resistance to aspirin and clopidogrel in Caucasians compared to minorities, with 11% versus 8% in regard to aspirin and 33% versus 17% to clopidogrel. Additionally, this study demonstrated 17% resistance to aspirin in males compared to 4% in females and 13% in males compared to 36% in females, respectively, regarding resistance to clopidogrel. No difference in inactivity to either aspirin or clopidogrel was detected between patients with stroke mechanisms of small or large vessel disease. Conclusions The present result demonstrated that a sizeable portion of the population has inefficacious activity in the setting of specific antiplatelet agents. Additionally, sex and ethnicity differences in responsiveness to aspirin or clopidogrel have been noted. Determining a patient's response to medications could provide opportunities to individualize treatment and better prevent future strokes. Further studies of a larger scale are indeed needed to apply this information to pursue individualized treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
不开花花发布了新的文献求助10
1秒前
1秒前
1秒前
2秒前
2秒前
My_magnum_opus的应助被七月流火采纳,获得30
3秒前
3秒前
3秒前
无聊的白米饭完成签到,获得积分10
3秒前
FashionBoy的应助被玲玲采纳,获得10
4秒前
脑洞疼的应助被玲玲采纳,获得10
4秒前
LIU发布了新的文献求助30
4秒前
彭于晏的应助被斯多姆采纳,获得10
5秒前
5秒前
一个句号完成签到,获得积分20
6秒前
xing_xing的应助被CWJ采纳,获得20
6秒前
llqq发布了新的文献求助10
6秒前
6秒前
向晚彭彭发布了新的文献求助10
6秒前
6秒前
星辰大海的应助被123采纳,获得10
6秒前
xixixi完成签到,获得积分10
6秒前
6秒前
7秒前
JamesPei的应助被科研眼镜蛇采纳,获得10
7秒前
7秒前
8秒前
秒速五厘米的应助被一个句号采纳,获得10
8秒前
haha完成签到,获得积分10
10秒前
Maestro_S的应助被寸烛驱夜采纳,获得10
10秒前
打打的应助被科研通管家采纳,获得10
10秒前
NexusExplorer的应助被科研通管家采纳,获得10
10秒前
10秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
10秒前
慕青的应助被科研通管家采纳,获得10
11秒前
酷波er的应助被科研通管家采纳,获得10
11秒前
Hello的应助被科研通管家采纳,获得100
11秒前
molihuakai的应助被科研通管家采纳,获得10
11秒前
乐乐的应助被科研通管家采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611